Drug-induced Hyperprolactinemia Results in Atypical Atypical Fracture.
Ingyu LeeDong-Wook SonJun Hyoung ParkJai Hyung ParkPublished in: Hip & pelvis (2021)
We report a case of bilateral femur fracture which may have resulted in part from long-term administration of antipsychotic agents. A 43-year-old female patient with pain in both thighs visited our clinic. We conducted X-ray and magnetic resonance imaging (MRI) examinations which revealed bilateral femur fractures. The right proximal femur had a complete fracture, and the left proximal femur had an incomplete fracture, both of which were in the subtrochanteric area. The patient was treated by intramedullary nailing in the right femur. Laboratory analysis showed hyperprolactinemia and hypogonadism. Bone mineral density analysis showed osteoporosis. Antipsychotic drug-induced hyperprolactinemia is a well-known phenomenon. Despite concerns about hyperprolactinemia induced osteoporotic fracture in patients treated with only prolactin-elevating medications, the issue has not been extensively studied. If hyperprolactinemia patients suffer from uncontrolled pain, we recommend MRI examination as surgeons should be aware of the possibility of osteoporotic fracture induced by hyperprolactinemia.
Keyphrases
- bone mineral density
- drug induced
- postmenopausal women
- liver injury
- magnetic resonance imaging
- body composition
- hip fracture
- case report
- chronic pain
- end stage renal disease
- contrast enhanced
- pain management
- chronic kidney disease
- primary care
- ejection fraction
- spinal cord injury
- multidrug resistant
- diffusion weighted imaging
- quality improvement
- endothelial cells
- prognostic factors
- finite element
- oxidative stress
- high glucose
- spinal cord
- postoperative pain